Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
Acute myelogenous leukemia (AML) is often associated with activating mutations in the receptor tyrosine kinase, Flt3, including internal tandem duplications (ITDs) within the regulatory juxtamembrane region. Previous studies have linked Flt3-ITD to the activation of the Fes protein tyrosine kinase i...
Main Authors: | Mark C Weir, Sabine Hellwig, Li Tan, Yao Liu, Nathanael S Gray, Thomas E Smithgall |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5519068?pdf=render |
Similar Items
-
CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML
by: Silvia Waldeck, et al.
Published: (2020-04-01) -
Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance.
by: Ravi K Patel, et al.
Published: (2019-01-01) -
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation
by: Ruiqi Zhu, et al.
Published: (2021-05-01) -
Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML
by: Pankit Vachhani, et al.
Published: (2016-01-01) -
Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells.
by: Bui Thi Kim Ly, et al.
Published: (2013-01-01)